CHARLES SCHWAB INVESTMENT MANAGEMENT INC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,198
-56.7%
33,4360.0%0.00%
Q2 2023$23,539
-72.6%
33,436
-65.1%
0.00%
Q1 2023$85,958
-35.1%
95,839
-14.7%
0.00%
Q4 2022$132,533
-83.8%
112,316
+3.5%
0.00%
Q3 2022$818,000
+21.9%
108,528
+1.9%
0.00%
Q2 2022$671,000
-9.0%
106,502
+20.1%
0.00%
Q1 2022$737,000
+63.4%
88,711
+2.3%
0.00%
Q4 2021$451,000
-22.2%
86,7580.0%0.00%
Q3 2021$580,000
-18.1%
86,758
+4.5%
0.00%
Q2 2021$708,000
+4.0%
83,031
+7.9%
0.00%
Q1 2021$681,000
-25.3%
76,931
+3.7%
0.00%
Q4 2020$912,000
+66.1%
74,188
+10.1%
0.00%
Q3 2020$549,000
-7.4%
67,387
+9.2%
0.00%
Q2 2020$593,000
+45.3%
61,701
+3.0%
0.00%
Q1 2020$408,000
-55.0%
59,879
-1.5%
0.00%
Q4 2019$906,000
+65.6%
60,803
+13.9%
0.00%
Q3 2019$547,000
-3.4%
53,3600.0%0.00%
Q2 2019$566,00053,3600.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders